Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
NorthSea Therapeutics
NorthSea Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
NorthSea Therapeutics
Total Funding
$69.4 M
NorthSea Therapeutics Summary
Company Summary
Overview
NorthSea Therapeutics is a clinical-stage biotech company developing oral, structurally engineered fatty acid therapeutics.
Type
Private
Status
Active
Founded
2017
HQ
Amsterdam, NL
|
view all locations
Website
https://www.northseatherapeutics.com
Cybersecurity rating
Sectors
Healthcare
biotech
therapy
Homepage
Table of Contents
Key People
Locations
Competitors
Key People
Rob de Ree,
CEO
David A. Fraser,
CSO
Maha Katabi,
CEO
Tore Skjæret,
VP Chemistry and CMC
and 3 others
Locations
View all
1 location detected
Amsterdam, NH
HQ
Netherlands
Paasheuvelweg 25, C6
Competitors and Similar Companies
Aligos Therapeutics
Healthcare - Public
Beike Biotechnology
Healthcare - Private
Orum Therapeutics
Healthcare - Private
Tubulis
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top